KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone
- 25 June 2019
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 38 (29) , 5766-5777
Abstract
We previously showed that KLF4, a gene highly expressed in murine prostate stem cells, blocks the progression of indolent intraepithelial prostatic lesions into aggressive and rapidly growing tumors. Here, we show that the anti-tumorigenic effect of KLF4 extends to PC3 human prostate cancer cells growing in the bone. We compared KLF4 null cells with cells transduced with a DOX-inducible KLF4 expression system, and find KLF4 function inhibits PC3 growth in monolayer and soft agar cultures. Furthermore, KLF4 null cells proliferate rapidly, forming large, invasive, and osteolytic tumors when injected into mouse femurs, whereas KLF4 re-expression immediately after their intra-femoral inoculation blocks tumor development and preserves a normal bone architecture. KLF4 re-expression in established KLF4 null bone tumors inhibits their osteolytic effects, preventing bone fractures and inducing an osteogenic response with new bone formation. In addition to these profound biological changes, KLF4 also induces a transcriptional shift from an osteolytic program in KLF4 null cells to an osteogenic program. Importantly, bioinformatic analysis shows that genes regulated by KLF4 overlap significantly with those expressed in metastatic prostate cancer patients and in three individual cohorts with bone metastases, strengthening the clinical relevance of the findings in our xenograft model.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA132641, P30CA016087, T32CA009161)
- New York State Stem Cell Science (C026719)
- U.S. Department of Health & Human Services | National Institutes of Health (S10OD010751)
- U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (CA181111)
- American Cancer Society (RSG-16-033-01-DDC)
- U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32AR064184)
- U.S. Department of Health & Human Services | NIH | National Institute on Aging (AG056169, K08AR069099)
This publication has 62 references indexed in Scilit:
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- BEDTools: a flexible suite of utilities for comparing genomic featuresBioinformatics, 2010
- The glycosaminoglycan-binding domain of PRELP acts as a cell type–specific NF-κB inhibitor that impairs osteoclastogenesisJournal of Cell Biology, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- The bone morphogenetic protein 1/Tolloid-like metalloproteinasesMatrix Biology, 2007
- Effect of mechanical stimuli on skeletal regeneration around implantsBone, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003
- Osteoclast differentiation and activationNature, 2003